Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Longboard Pharmaceuticals Inc (NQ: LBPH ) 59.50 -0.19 (-0.32%) Streaming Delayed Price Updated: 4:00 PM EST, Nov 4, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Longboard Pharmaceuticals Inc < Previous 1 2 3 4 5 Next > Longboard Pharmaceuticals Reports Full Year 2022 Financial Results and Key Corporate Initiatives March 02, 2023 From Longboard Pharmaceuticals, Inc. Via Business Wire Earnings Preview: Longboard Pharmaceuticals March 01, 2023 Via Benzinga Longboard Pharmaceuticals to Report Full Year 2022 Financial Results and Key Corporate Initiatives on March 2, 2023 February 23, 2023 From Longboard Pharmaceuticals, Inc. Via Business Wire Longboard Pharmaceuticals Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares in Public Offering of Common Stock February 10, 2023 From Longboard Pharmaceuticals Via Business Wire Stocks That Hit 52-Week Lows On Friday February 04, 2022 On Friday, 209 companies set new 52-week lows. Interesting Facts About Today's 52-Week Lows: Meta Platforms (NASDAQ:FB) was the largest firm on a market cap... Via Benzinga Longboard Pharmaceuticals Announces Pricing of Public Offering of Common Stock February 07, 2023 From Longboard Pharmaceuticals, Inc. Via Business Wire Longboard Pharmaceuticals Announces Commencement of Public Offering of Common Stock February 07, 2023 From Longboard Pharmaceuticals, Inc. Via Business Wire Longboard Pharmaceuticals Announces Positive Topline Data from a Phase 1 Clinical Study Evaluating Central Nervous System Pharmacokinetics and Pharmacodynamics of LP352 in Healthy Volunteers December 05, 2022 From Longboard Pharmaceuticals, Inc. Via Business Wire Longboard Pharmaceuticals’ Presence at American Epilepsy Society (AES) Annual Meeting Reinforces Ongoing Commitment to the Rare Epilepsy Community November 29, 2022 From Longboard Pharmaceuticals, Inc. Via Business Wire Longboard Pharmaceuticals to Present at Guggenheim’s Healthcare Talks 4th Annual Immunology and Neurology Day November 08, 2022 From Longboard Pharmaceuticals, Inc. Via Business Wire Longboard Pharmaceuticals: Q3 Earnings Insights November 03, 2022 Longboard Pharmaceuticals (NASDAQ:LBPH) reported its Q3 earnings results on Thursday, November 3, 2022 at 08:30 AM. Here's what investors need to know about the announcement. Via Benzinga Longboard Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2022 Financial Results November 03, 2022 From Longboard Pharmaceuticals, Inc. Via Business Wire Longboard Pharmaceuticals to Participate in the Cantor Neurology & Psychiatry Conference September 29, 2022 From Longboard Pharmaceuticals, Inc. Via GlobeNewswire The Daily Biotech Pulse: BioXcel's Igalmi Gets FDA Nod, Citius Spikes On Positive Phase 3 Data, Iovance Receives Positive Regulatory Feedback For Skin Cancer Therapy April 06, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours. Via Benzinga This Healthcare Stock Dipped Over 30%; Here Are 83 Biggest Movers From Yesterday August 18, 2022 Gainers Via Benzinga Why Blue Water Vaccines Is Trading Higher By Around 80%, Here Are 61 Stocks Moving In Wednesday's Mid-Day Session August 17, 2022 Gainers Blue Water Vaccines, Inc. (NASDAQ: BWV) shares jumped 79.5% to $4.57 after the company announced it plans to explore the potential development of a novel monkeypox vaccine using its norovirus... Via Benzinga The Week Ahead In Biotech (April 3-April 9): BioXcel FDA Decision, Neurology Conference Presentations Take The Spotlight April 03, 2022 Biopharma stocks outperformed the broader market in the week ending April 2, thereby recouping the losses from the previous week. Clinical readouts and FDA decisions were among the chief catalysts that... Via Benzinga Carnival Surges Over 12%, Here's 75 Biggest Movers From Friday June 27, 2022 Gainers USA Truck, Inc. (NASDAQ: USAK) shares climbed 112.6% to close at $31.00 on Friday. DB Schenker and USA Truck announced plans to combine and create premier North American transportation... Via Benzinga Longboard Pharmaceuticals: Q1 Earnings Insights March 04, 2022 Longboard Pharmaceuticals (NASDAQ:LBPH) reported its Q1 earnings results on Thursday, March 3, 2022 at 04:05 PM. Here's what investors need to know about the... Via Benzinga Stocks That Hit 52-Week Lows On Thursday June 23, 2022 On Thursday, 216 stocks hit new 52-week lows. Via Benzinga 40 Stocks Moving In Tuesday's Mid-Day Session July 13, 2021 Gainers Orbsat Corp. (NASDAQ: OSAT) shares jumped 81.7% to $12.12 after the company announced its Global Telesat Communications unit has entered into an agreement with Alibaba.... Via Benzinga Mid-Morning Market Update: Markets Mixed; JPMorgan Beats Q2 Views July 13, 2021 Following the market opening Tuesday, the Dow traded down 0.25% to 34,908.83 while the NASDAQ rose 0.15% to 14,754.89. The S&P also fell, dropping 0.07% to 4,381.77. The U.S.... Via Benzinga Topics Stocks Exposures US Equities The Daily Biotech Pulse: Hookipa, PDS Biotech Report Positive Data, Ironwood CFO To Depart, Decision Day For Vertex June 08, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 7) Agios Pharmaceuticals, Inc... Via Benzinga 60 Biggest Movers From Yesterday June 15, 2021 Gainers RAPT Therapeutics, Inc. (NASDAQ: RAPT) shares jumped 115.5% to settle at $40.02 on Monday as the company announced topline results from its Phase 1b trial of RPT193 as... Via Benzinga 64 Biggest Movers From Friday June 14, 2021 Gainers Kanzhun Limited (NASDAQ: BZ) shares climbed 95.8% to close at $37.20 on Friday after the company priced its IPO at $19 per share. Novan, Inc. (NASDAQ: NOVN) shares gained... Via Benzinga Topics Initial Public Offering Exposures Securities Market The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom May 06, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 5) AbbVie Inc. (NYSE: ABBV)... Via Benzinga Exposures Product Safety The Daily Biotech Pulse: Athenex, NeoGenomics And Amryt In M&A Mix, European Nod For Roche's Cancer Immunotherapy, Earnings Deluge Continues May 05, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 4) AbbVie Inc. (NYSE: ABBV)... Via Benzinga The Daily Biotech Pulse: Vaxart Rebounds On Strong Vaccine Data, Pfizer's Beat-And-Raise Quarter, BioLineRx Data May 04, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 3) AbbVie Inc. (NYSE: ABBV)... Via Benzinga The Daily Biotech Pulse: FDA Rejection For Protalix, Amgen Q1 Trail Estimates, Pfizer Goes Shopping April 28, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 27) Aldeyra Therapeutics, Inc... Via Benzinga Exposures Product Safety The Daily Biotech Pulse: Quidel Slides On Negative Pre-Announcement, Roche Gets Positive EMA Committee Recommendation, 3 IPOs April 23, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 22) AtriCure, Inc. (NASDAQ:... Via Benzinga < Previous 1 2 3 4 5 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
